Curex GLP-1 Review 2026: The Regulatory Window Has Shifted - Here's What Compounded Semaglutide at $149 Gets You Now

MIAMI, April 28, 2026 (Newswire.com) - Disclosure: This article is a paid promotional feature. A commission may be earned through links in this article at no additional cost to the reader. This content is for informational purposes only and does not constitute medical advice. Curex, Inc. is not a healthcare provider; clinical decisions are made by licensed, independent providers. Compounded medications offered through the Curex platform are not FDA-approved finished drugs and have not been evaluated by the FDA for safety or effectiveness. Always consult a qualified healthcare professional before starting any prescription treatment. Nothing in this article is intended to encourage the use of any medication without proper medical supervision. Prescription GLP-1 medications carry serious potential side effects, including a Black Box Warning for thyroid tumors. Read all safety information and speak with a licensed clinician before pursuing any GLP-1 treatment.

Curex GLP-1 Program Review 2026 Highlights Compounded Semaglutide and Tirzepatide Options With Transparent Pricing and Telehealth Access

The compounded GLP-1 landscape that most people are reading about online is not the same landscape that exists today.

The FDA resolved the semaglutide injection shortage as of February 21, 2025. The tirzepatide injection shortage was resolved before that, on December 19, 2024. Those shortage declarations were the primary legal framework that allowed compounding pharmacies to produce semaglutide and tirzepatide at scale for telehealth programs. With the shortages resolved, that framework has narrowed - and the regulatory environment every compounded GLP-1 platform is operating in has changed meaningfully from what it was when most articles covering this space were written.

That context matters before evaluating any compounded GLP-1 program in 2026 - including Curex.

Curex is a telehealth platform that, according to its published GLP-1 page, currently offers compounded semaglutide starting at $149 per month and compounded tirzepatide starting at $199 per month, with no membership fee, and with both injectable and needle-free oral dissolving tablet formats available. The program is operational. But informed evaluation of it requires understanding both what the platform offers and the current regulatory environment it operates within.

This review covers both - the program structure, the pricing reality, the refund terms (including a nuance buried in the Terms of Use that most readers miss), the four medication formats, the safety information you need, and the questions worth verifying directly before you commit to anything.

Critical upfront: Compounded GLP-1 medications are not FDA-approved. The FDA has issued specific warnings about risks associated with unapproved compounded GLP-1 products, including dosing errors and adverse events. All treatment decisions must be made by a licensed healthcare provider based on your individual health profile. This article is a starting point for research, not a substitute for that conversation.

View current Curex GLP-1 program details on the official Curex website

What Changed for Compounded GLP-1 Programs in 2025 - And Why It Matters Right Now

Most reviews of compounded GLP-1 telehealth programs were written during the shortage period - when the FDA's shortage declarations for semaglutide and tirzepatide provided compounding pharmacies with a broader legal basis to produce these medications. That period is over.

Here is what changed, stated factually:

The FDA shortage declarations ended. The FDA determined the tirzepatide injection shortage resolved as of December 19, 2024. The semaglutide injection shortage resolved as of February 21, 2025. These determinations narrowed - but did not eliminate - the legal basis for compounding these active ingredients. State-licensed pharmacies operating under Section 503A of the Federal Food, Drug, and Cosmetic Act can still compound medications for individual patients based on a valid prescription. But the broader Section 503B outsourcing facility pathway that enabled large-scale production under shortage rules has become more restricted for these specific drugs.

What this means for Curex specifically: This article cannot make a determination about Curex's current regulatory standing - that requires verification directly with the platform, the prescribing clinician, and the dispensing pharmacy. What it means for any reader is that verifying current status is not optional. The regulatory ground has shifted since most of the content ranking on this topic was published, and the responsible approach is to verify before starting, not after.

What this does not mean: The shortage resolutions do not automatically make compounded GLP-1 programs illegal or shut down. Compounding for individual patients under valid prescriptions remains a regulated but available pathway. The landscape is more complex than it was - which is exactly why current verification matters.

This is the context no other review of Curex is providing right now. It's also the most important thing to understand before you evaluate any compounded GLP-1 platform in 2026.

What Is Curex - and Who Is Actually Involved in Your Care?

Curex, Inc. is a telehealth technology platform - not a clinic, not a pharmacy, and not a prescriber. This distinction is not semantic. It directly affects who makes decisions about your prescription, what relationship you have with each party, and who to contact when questions arise at different stages of the process.

Per Curex's own Terms of Use, three separate entities are involved. All three play distinct roles:

Curex, Inc. (the platform) provides the technology infrastructure - scheduling, payment processing, secure communications, and coordination. According to the company's Terms of Use, Curex is not a healthcare provider and does not provide medical care or make clinical decisions. When you submit your intake information, you are entering a relationship with a technology company that facilitates access to healthcare services - not a relationship with a clinical practice.

Licensed Independent Providers (the clinicians) are the healthcare professionals who review your medical history and determine whether a GLP-1 prescription is appropriate for your specific situation. These are licensed clinicians who operate independently. According to the platform's terms, a prescription is not guaranteed - the reviewing clinician makes that determination based entirely on your individual health profile. The platform cannot and does not influence that decision.

Partner Pharmacies (the compounders) within Curex's licensed pharmacy network prepare and dispense your medication once a prescription is issued. According to the company, each pharmacy in their network undergoes third-party testing through FDA and DEA-certified labs, covering identity, potency, sterility, and endotoxin levels. These pharmacies do not dispense Ozempic®, Wegovy®, Zepbound®, or Mounjaro® - and Curex is not affiliated with or endorsed by Novo Nordisk® or Eli Lilly®.

Understanding this three-entity structure before you begin helps set accurate expectations about the process, who makes clinical decisions, and where to direct questions at each stage.

The Four Medication Formats: What Curex Currently Offers

According to Curex's published GLP-1 product page, four compounded medication options are currently available through the program - two injectable, two oral. Here is what each involves:

Compounded Semaglutide - Weekly Injectable

Prepared by a licensed partner pharmacy using semaglutide as an active ingredient, administered as a weekly self-injection. According to Curex's published pricing, this option starts at $149 per month, with prescription, medication, and shipping included.

Compounded Tirzepatide - Weekly Injectable

Uses tirzepatide as its active ingredient, also administered weekly. According to Curex's published pricing, this option starts at $199 per month, with prescription, medication, and shipping included.

Compounded Semaglutide ODT - Daily Oral Dissolving Tablet

For people who want to avoid injections entirely, Curex offers a needle-free alternative: an oral dissolving tablet (ODT) that dissolves under the tongue - no needles, no syringes, no measuring. According to the company, these tablets are easier to store and travel with, and dosing is precise without the variability that can accompany self-administered injections. Starts at $149 per month with prescription, medication, and shipping included, per the Curex GLP-1 page.

Compounded Tirzepatide ODT - Daily Oral Dissolving Tablet

The same needle-free format for compounded tirzepatide. Starts at $199 per month, per Curex's published pricing.

According to the Curex website, all four options are currently in stock with an estimated shipping window of approximately 1-2 business days from the partner pharmacy once a prescription is issued. Availability is subject to change - verify directly before beginning intake.

The Most Important Thing to Understand About These Medications

Read this section carefully. It is the most consequential part of this article.

Compounded semaglutide and compounded tirzepatide are not Ozempic®, Wegovy®, Zepbound®, or Mounjaro®. They are not generic versions of those medications. They are custom-compounded formulations prepared by licensed pharmacies - and they are not FDA-approved finished drug products.

According to Curex's own FAQ: "Compounded medications are not FDA-approved for safety or effectiveness. A prescription is required. Results may vary from person to person."

The FDA oversees compounding pharmacies under separate federal and state regulatory frameworks, but compounded medications are not reviewed or approved by the FDA as finished products. The FDA has issued specific public warnings about compounded GLP-1 products, including documented concerns about dosing errors, mislabeling, and adverse events.

Per Curex's FAQ, the company's providers do not prescribe Ozempic®, Wegovy®, Zepbound®, or Mounjaro®. If those specific FDA-approved medications are what you are looking for, a traditional prescribing provider or licensed pharmacist is the appropriate channel.

The ODT formats are also compounded formulations - not FDA-approved finished products - and clinical equivalence to FDA-approved injectable or oral GLP-1 medications should not be assumed.

None of this is specific to Curex. These limitations apply to every compounded GLP-1 program. The point is that you understand precisely what you are - and are not - considering before you proceed.

View current Curex GLP-1 program details and safety information

The Pricing Reality: What "No Membership Fee" Actually Covers

The GLP-1 telehealth space has a well-documented pricing transparency problem. Platforms routinely advertise a low "starting at" monthly figure while burying mandatory membership fees, per-consultation charges, or lab costs in a second layer of terms that most people don't find until after they've entered their payment information.

According to Curex's published GLP-1 page, the platform markets itself as a direct response to that problem. Their stated position, quoted from the company's website: "We believe you shouldn't have to read the fine print. Our prices are honest and affordable. We don't have membership fees or other additional charges."

Curex markets its program as having no membership fee and no hidden charges. Based on the company's published pricing, here is what each monthly fee includes:

• Online consultation and independent provider review

• Your prescription, if the reviewing clinician determines it is appropriate

• The compounded medication itself

• Free shipping directly to your door

• Ongoing provider access for follow-ups, dosage adjustments, and lab result reviews

What is not covered, per the company's FAQ: If the reviewing clinician orders labs or recommends additional medications such as metformin or vitamin B12, those costs fall outside the plan. Curex notes that insurance may be usable for those items. The base monthly price covers the core compounded medication program - individualized clinical recommendations may carry separate costs.

Pricing, eligibility, availability, and treatment terms are subject to change. Always verify current details directly with Curex before completing your intake or submitting payment.

Insurance, HSA, and FSA

Curex markets its program as not requiring insurance. According to the company's FAQ, FSA and HSA cards are accepted. Many direct-to-consumer prescription programs are not covered by traditional insurance plans, but coverage policies vary. Always confirm benefits directly with your insurer - some HSA/FSA plans may reimburse qualifying telehealth or prescription expenses. Check your specific plan rules before assuming reimbursement.

Step-by-Step: Exactly What Happens After You Submit Your Information

One of the most common questions about telehealth GLP-1 programs is simply: what actually happens once I fill out the form? Here is how Curex describes the process on its published website.

Step 1 - Complete Your Intake: You fill out a medical history questionnaire entirely online. According to the company, this takes a few minutes. Depending on your state of residence and the specifics of your medical history, the reviewing clinician may require a video visit - or may complete the review through asynchronous text-based communication. The clinician's judgment and your state's telehealth regulations determine which applies.

Step 2 - Independent Provider Review: A licensed, independent medical provider reviews your intake information and determines whether a GLP-1 prescription is clinically appropriate for you. This is not a formality - a prescription is not guaranteed, and the determination is based entirely on your individual health profile. Curex, as a platform, cannot and does not influence that clinical decision.

Step 3 - Medication Dispensed and Shipped: If a prescription is issued, your compounded medication is prepared by a licensed partner pharmacy and ships free to your door. According to the company's published website, the estimated shipping window is approximately 1-2 business days from the partner pharmacy.

Step 4 - Ongoing Provider Access: According to Curex, unlimited access to follow-up communication, dosage adjustments, and lab result reviews is included in the program. Initial dosing is individualized by the reviewing provider, and titration - the gradual adjustment of dosage toward an optimal therapeutic level - is built into the program structure. Providers may also recommend additional medications or supplements as part of a personalized plan, per the Curex FAQ.

Where Curex Currently Operates

According to the Curex website, the platform does not currently serve the following states: Alaska, Arkansas, Connecticut, Hawaii, Massachusetts, New Mexico, and Missouri. State availability is subject to change - verify directly on the Curex website before beginning intake.

The Refund and Cancellation Terms: Read This Before You Pay Anything

This is the section most people skip - and the one that generates the most friction after the fact. There is a specific nuance in Curex's refund language that deserves direct attention before you enter payment information. Not flagging it would be doing the reader a disservice.

Curex's FAQ states: "If compounded semaglutide or compounded tirzepatide are not prescribed, we will provide a full refund."

Clear and reassuring. However, Curex's Terms of Use include a separate qualifier: "Completion of a clinical consultation constitutes a non-refundable service fee of up to $100, regardless of whether a prescription is dispensed or shipped."

These two statements are not necessarily contradictory - Curex may provide a full medication refund while retaining a consultation fee of up to $100. But a reader who only reviewed the FAQ would not anticipate the consultation fee language in the Terms. That gap is worth knowing before you commit.

Beyond the prescription scenario: Curex's Terms also state that all fees are generally non-refundable once a product enters the fulfillment process - defined as compounding, preparation, or shipment - and that no refunds or credits are issued for partially used subscription periods.

Read both the FAQ and the full current Terms of Use before submitting payment. Policies are subject to change; verify directly on the Curex website, not from this article alone.

To cancel or inquire about account status, per Curex's published Terms: email hi@getcurex.com or call (857) 240-1080.

Safety Information: What You Need to Know Before Starting Any GLP-1 Program

This section is a high-level overview only. It does not include all possible risks, warnings, or drug interactions. Patients should review full prescribing information and pharmacy-provided safety materials before use, and discuss all questions with a licensed clinician or pharmacist.

Compounded semaglutide and tirzepatide are prescription-strength medications with serious potential side effects. Both carry a Black Box Warning - the FDA's most serious warning designation - for thyroid C-cell tumors, including thyroid cancer. Do not use either if you or a family member have a personal history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2).

Serious side effects requiring immediate medical attention include:

• Severe nausea or vomiting leading to dehydration

• Kidney dysfunction - dehydration from GI symptoms can worsen pre-existing kidney conditions

• Pancreatitis - severe, persistent abdominal or back pain

• Acute gallbladder disease - upper right abdominal pain, fever, or jaundice

• Worsening diabetic retinopathy

• Severe allergic reaction - facial swelling, difficulty breathing, rapid heartbeat

• Worsening depression or suicidal thoughts - monitor mood and report changes to your provider immediately

Common side effects include nausea, diarrhea, vomiting, constipation, abdominal discomfort, fatigue, and injection site reactions for injectable formats.

Both medications can interact with insulin, sulfonylureas, thyroid medications, and medications with narrow therapeutic windows such as warfarin. Compounded tirzepatide may reduce the effectiveness of oral contraceptives - discuss alternative birth control with your provider before starting and following any dose increase.

Per Curex's Terms of Use, the online service is intended for adults 18 years of age and older.

To report adverse reactions, contact the FDA at 1-800-FDA-1088 or visit fda.gov/medwatch. In a medical emergency, call 911 immediately.

Who This Program May Be Worth Evaluating - and Who It Likely Is Not

No article can determine whether a GLP-1 program is clinically appropriate for you. That is a decision for a licensed healthcare provider who knows your full medical history. What this section can do is help you quickly identify whether the Curex program structure is worth exploring further with that provider.

Curex May Be Appropriate to Evaluate Further With a Licensed Healthcare Provider for Adults Who:

Want published, all-in pricing with no membership fee: Curex's published pricing model ($149-$199/month per the company's website) offers front-loaded clarity that is genuinely useful before committing to any telehealth GLP-1 program. Pricing is subject to change - always verify before paying.

Have already discussed compounded GLP-1 options with a clinician and understand what they are: If you've had an informed conversation about how compounded formulations differ from FDA-approved medications and have determined this path is worth exploring, the Curex platform is designed to facilitate that.

Want a needle-free GLP-1 format: The ODT options are one of Curex's more distinctive features - not every telehealth GLP-1 platform offers a non-injectable format. If this matters to you, it's worth a direct conversation with a provider about whether the ODT format is appropriate for your situation.

Prefer a straightforward self-pay model: Curex markets its program as insurance-free with published pricing. FSA and HSA cards are accepted, per the company's FAQ.

Live in a state Curex currently serves: The program does not operate in Alaska, Arkansas, Connecticut, Hawaii, Massachusetts, New Mexico, or Missouri. Confirm availability before starting intake.

Other Options Are Likely More Suitable for People Who:

Are seeking FDA-approved GLP-1 medications specifically: Curex's program offers compounded formulations only. Ozempic®, Wegovy®, Zepbound®, and Mounjaro® are not available through this platform. For those medications, a traditional prescribing provider or pharmacist is the appropriate channel.

Prefer or require in-person clinical evaluation before starting a prescription program: Curex's model is entirely online. If your health situation warrants an in-person examination first, start there.

Have complex medical histories requiring intensive clinical oversight: The telehealth model has real limitations for patients managing multiple comorbidities or complex medication interactions. In-person specialist care is more appropriate in those cases.

Questions Worth Discussing With a Healthcare Provider Before You Start

• Am I a clinically appropriate candidate for a GLP-1 medication program?

• Do I understand how compounded GLP-1 medications differ from FDA-approved options - and have I verified the current regulatory status of any platform I am considering?

• Are there existing medications, conditions, or risk factors that should be evaluated before I begin?

• Have I read and understood both the FAQ and the full Terms of Use before submitting payment?

• Is Curex currently operating in my state?

View current Curex GLP-1 program details and eligibility information

How Curex Positions Itself in the Current Compounded GLP-1 Market

The compounded GLP-1 telehealth space expanded rapidly as demand for semaglutide and tirzepatide outpaced the supply of FDA-approved brand-name versions. That rapid growth produced both genuine innovation and serious problems: opaque pricing, questionable compounding practices, and escalating regulatory scrutiny. The shortage resolutions of late 2024 and early 2025 narrowed the landscape further. What remains is a smaller, more carefully regulated field - which makes evaluating individual platforms more important, not less.

On pricing structure: Curex markets itself specifically on the absence of membership fees and hidden charges. According to the company's published page, their all-in pricing covers consultation, medication, and shipping. Verify directly before committing - pricing structures can change.

On format variety: The availability of oral dissolving tablet formats alongside injectables is a meaningful differentiator. Needle aversion is a real barrier for a significant portion of people who might otherwise explore GLP-1 options, and not every telehealth platform offers an alternative delivery mechanism. ODT formats are compounded formulations - not FDA-approved finished drugs - and equivalence to injectable FDA-approved products should not be assumed.

On regulatory standing: This article reports the shortage resolution dates and their general implications. It does not make a determination about Curex's current regulatory standing - that requires verification directly with the platform, the prescribing clinician, and the dispensing pharmacy. The reader is the only person in a position to conduct that verification for their specific situation.

Regulatory notice: The GLP-1 telehealth category has been under ongoing scrutiny from both the FDA and FTC. Compliance standards, enforcement priorities, and compounding rules can shift. The responsibility to verify current regulatory standing rests with the patient and their healthcare provider. This article reflects information available at the time of publication and cannot account for changes that occur after that date.

How to Get Started - and What to Verify First

If you and a healthcare provider have discussed a compounded GLP-1 program and determined it is worth exploring, here is how the Curex process works according to the company's published information - along with the verification steps that should happen before you submit anything.

Before you begin: Verify that Curex is currently operating in your state. Confirm the current regulatory status of their program and pharmacy network directly with the company. Read both the FAQ and the full Terms of Use - particularly the refund and cancellation section - before entering payment information.

The intake process: Everything is completed online. You fill out a medical history questionnaire the company describes as taking a few minutes. An independent licensed provider reviews your information and determines whether a prescription is appropriate. Depending on your state and health history, that review may happen asynchronously or may require a video consultation. If a prescription is issued, your medication ships free from a partner pharmacy, with ongoing provider access included for follow-ups and adjustments.

Contact Information

According to Curex's published contact page:

• Phone/Text: (857) 240-1080

• Email: hi@getcurex.com

• Address: 777 Brickell Ave #500-95053, Miami, FL 33131

Always verify current terms, pricing, and availability directly with Curex before submitting your intake form or payment information. Program details are subject to change.

View current Curex GLP-1 program details on the official Curex website

Final Verdict: Is Curex Worth Evaluating for Compounded GLP-1 Access in 2026?

The honest answer is: it depends on whether you do the verification work first.

Curex offers genuine differentiators - published all-in pricing with no membership fee, both injectable and needle-free tablet formats, a fully online process, and a straightforward self-pay structure. For adults who understand what compounded medications are, have discussed this path with a licensed clinician, and have verified the current status of the platform and its pharmacy partners, this program may be appropriate to evaluate further.

But the broader context cannot be ignored. The regulatory landscape for compounded GLP-1 programs has shifted materially since most content on this topic was written. The shortage declarations that provided the broadest legal basis for compounding at scale have ended. That does not mean programs like Curex are no longer operating - it means the due diligence required before starting is higher now than it was twelve months ago.

The platform is not a fit for everyone. It does not offer FDA-approved GLP-1 medications. Its refund terms contain a consultation fee nuance worth reading before you pay. It is not available in every state. And like every compounded GLP-1 program, it operates in a regulatory environment that continues to evolve.

Use this article as a starting point for an informed conversation with your healthcare provider - not as the final word on whether this program is right for you. A licensed clinician who knows your full health history, and who can verify current program standing, is your most important resource in making this decision.

View current Curex GLP-1 program details and get started

Frequently Asked Questions

Is the compounded GLP-1 market still operating after the FDA shortage resolutions?
The FDA resolved the semaglutide injection shortage on February 21, 2025, and the tirzepatide injection shortage on December 19, 2024. These resolutions narrowed - but did not eliminate - the legal basis for compounding these medications. Compounding for individual patients under valid prescriptions through licensed 503A pharmacies remains a regulated but available pathway. However, the regulatory landscape is evolving, and patients should verify the current status of any compounded GLP-1 program directly with the platform, their prescribing clinician, and the dispensing pharmacy before beginning treatment.

Does Curex prescribe Ozempic® or Wegovy®?
No. According to Curex's FAQ, the platform's providers do not prescribe Ozempic®, Wegovy®, Zepbound®, or Mounjaro®. Curex offers compounded semaglutide and tirzepatide, which are not the same as those FDA-approved medications and are not generics of them. Curex is not affiliated with or endorsed by Novo Nordisk® or Eli Lilly®.

Is compounded semaglutide FDA-approved?
No. Compounded semaglutide - like all compounded medications - is not reviewed or approved by the FDA as a finished product. The FDA has issued specific warnings about compounded GLP-1 products. This is disclosed explicitly by Curex in their FAQ and on their product page.

What does the monthly price actually include?
According to Curex's published pricing page, the monthly fee covers the provider consultation, your prescription if issued, the compounded medication, and free shipping. There is no membership fee, per the company's marketing. Labs and additional medications a clinician may recommend are not covered by the plan, though Curex notes insurance may be usable for those items.

What happens to my refund if I'm not prescribed medication?
Curex's FAQ states a full refund is provided if compounded semaglutide or tirzepatide is not prescribed. However, Curex's Terms of Use separately state that completion of a clinical consultation constitutes a non-refundable service fee of up to $100. Read both documents before submitting payment, and verify current terms directly on the Curex website, as policies are subject to change.

Can I pay with HSA or FSA?
According to Curex's FAQ, yes - FSA and HSA cards are accepted. Verify eligibility with your specific plan administrator before assuming your expenses will be reimbursed, as HSA/FSA rules vary by plan.

What states does Curex currently serve?
As of the time of publication, Curex does not serve Alaska, Arkansas, Connecticut, Hawaii, Massachusetts, New Mexico, or Missouri. State availability is subject to change - verify directly on the Curex website before beginning intake.

Do I have to inject, or is there a pill option?
Curex offers both injectable and oral dissolving tablet (ODT) formats for compounded semaglutide and tirzepatide. ODT tablets dissolve under the tongue - no needles or syringes required. These are also compounded formulations, not FDA-approved finished drugs, and clinical equivalence to injectable FDA-approved GLP-1 medications should not be assumed.

Does Curex require video visits?
According to the company's FAQ, most reviews are completed 100% online without a required video visit. However, depending on your state of residence and medical history, the reviewing clinician may require a video consultation. This is determined by the clinician and applicable state telehealth regulations - not by the patient's preference.

Is Curex legit?
Curex, Inc. operates as a telehealth platform facilitating access to independent licensed clinicians and licensed compounding pharmacies. The company's Terms of Use, FAQ, and safety information are publicly available and consistent with standard telehealth operating disclosures. Evaluating "legitimacy" in this space also requires verifying the current regulatory standing of the platform and its pharmacy partners - which is subject to change and requires direct verification before starting any program.

Disclaimers

Content and Medical Disclaimer: This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. The descriptions of potential benefits are not guarantees and are not a substitute for an individualized medical evaluation. Curex offers compounded prescription medications that require evaluation by a licensed, independent clinician. The information provided here does not replace the professional judgment of your healthcare provider.

Professional Medical Disclaimer: This article is educational and does not constitute medical advice. Compounded GLP-1 medications are not a substitute for prescribed medical treatment as determined by a licensed clinician. If you are currently taking medications, have existing health conditions, are pregnant or nursing, or are considering any major changes to your health regimen, consult your physician before starting any compounded GLP-1 program or prescription treatment. Do not change, adjust, or discontinue any medications or prescribed treatments without your physician's guidance and approval.

Compounded Medication Notice: Compounded semaglutide and tirzepatide offered through the Curex platform are compounded prescription medications prepared by licensed pharmacies based on individual prescriptions. Compounded medications are not reviewed or approved by the FDA as finished products. They are not the same as, nor are they generics of, FDA-approved medications such as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. The FDA has issued warnings about risks associated with compounded GLP-1 products, including dosing errors and adverse events. Curex is not affiliated with or endorsed by Novo Nordisk® or Eli Lilly®.

Results May Vary: Individual results will vary based on factors including age, baseline health condition, lifestyle factors, consistency of use, genetic factors, current medications, adherence to clinician guidance, and other individual variables. Results are not guaranteed.

FTC Affiliate Disclosure: This article contains affiliate links. If you purchase through these links, a commission may be earned at no additional cost to you. This compensation does not influence the accuracy, neutrality, or integrity of the information presented. All descriptions are based on publicly available information from Curex's official website and published terms.

Pricing Disclaimer: All prices, program details, promotional offers, and terms mentioned were accurate based on publicly available Curex website information at the time of publication (April 2026) but are subject to change without notice. Always verify current pricing and terms on the official Curex website before submitting payment or beginning intake.

Publisher Responsibility: The publisher of this article has made every effort to ensure accuracy at the time of publication based on publicly available information. We do not accept responsibility for errors, omissions, or outcomes resulting from the use of the information provided. Readers are encouraged to verify all details directly with Curex and their healthcare provider before making decisions.

Insurance Coverage Note: Many direct-to-consumer prescription programs are not covered by traditional insurance plans, but coverage policies vary. Always confirm benefits directly with your insurer. Some HSA/FSA plans may reimburse qualifying expenses; check your specific plan rules before assuming reimbursement.

Regulatory Scrutiny Notice: The compounded GLP-1 telehealth category has been under ongoing regulatory scrutiny from the FDA and FTC. The FDA shortage declarations for semaglutide and tirzepatide were resolved in early 2025, which changed the regulatory framework under which compounding pharmacies produced these medications at scale. Patients should verify the current compliance, pharmacy standing, and regulatory status of any compounded GLP-1 platform directly before proceeding. Regulations governing compounded medications continue to evolve, and enforcement priorities can shift. This article reflects information available at the time of publication (April 2026) and cannot account for changes that occur after that date.

SOURCE: Curex

Source: Curex